Contents

Search


NAD+ ADP-ribosyltransferase or poly ADP-ribose polymerase

Function: - NAD+ ADP-ribosyltransferase binds to DNA damage caused by ionizing radiation & alkylating agents & automodifies itself with NAD forming branched chain polymers of ADP ribose at several sites - polymers are short-lived (1-2 min) because poly ADP-ribose polymerase always occurs together with poly ADP ribose glycohydrolase - the overall process consumes NAD & produces nicotinamide, ADP-ribose & branched oligo-(ADP-ribose) molecules - PARP deficient mutants are not deficient in DNA repair; however, PARP may serve a role in recognition of DNA damage, recruitment of the repair apparatus to the site of DNA damage & as a meter of the overall extent of genomic damage sustained Expression: - there are about 1 million molecules of PARP in mammalian nuclei Compartment: - the enzyme is conserved in most eukaryotes - not expressed in yeast Pharmacology: - olaparib (Lynparza) is a poly ADP-ribose polymerase inhibitor FDA-approved to treat advanced ovarian cancer with germline BRCA mutations - niraparib (Zejula) is a poly ADP-ribose polymerase inhibitor FDA-approved for maintenance treatment of recurrent epithelial cancers (ovarian cancer, fallopian tube cancer, primary peritoneal cancer) - PARP inhibitors are FDA-approved to treat androgen-independent metastatic prostate cancer

Interactions

molecular events

Related

PARP inhibitor poly(ADP-ribose)glycohydrolase (pARG)

Specific

poly [ADP-ribose] polymerase 10; PARP-10; ADP-ribosyltransferase diphtheria toxin-like 10; ARTD10 (PARP10) poly [ADP-ribose] polymerase 11 (PARP-11, PARP11, C12orf6) poly [ADP-ribose] polymerase 12; PARP-12; zinc finger CCCH domain-containing protein 1 (PARP12, ZC3HDC1) poly [ADP-ribose] polymerase 14; PARP-14; ADP-ribosyltransferase diphtheria toxin-like 8; ARTD8; B aggressive lymphoma protein 2 (PARP14, BAL2, KIAA1268) poly [ADP-ribose] polymerase 15; PARP-15; ADP-ribosyltransferase diphtheria toxin-like 7; ARTD7; B-aggressive lymphoma protein 3 (PARP15, BAL3) poly [ADP-ribose] polymerase 16; ADP-ribosyltransferase diphtheria toxin-like 15; ARTD15; mono [ADP-ribose] polymerase PARP16; PARP-16 (PARP16, C15orf30) poly [ADP-ribose] polymerase 1; PARP-1; NAD(+) ADP-ribosyltransferase 1; ADPRT 1; poly[ADP-ribose] synthase 1 (PARP1, ADPRT, PPOL) poly [ADP-ribose] polymerase 2; PARP-2; hPARP-2; NAD(+) ADP-ribosyltransferase 2; ADPRT-2; poly[ADP-ribose] synthase 2; pADPRT-2 (PARP2 ADPRT2 ADPRTL2) poly [ADP-ribose] polymerase 3; PARP-3; hPARP-3; IRT1; NAD+ ADP-ribosyltransferase 3; ADPRT-3; poly[ADP-ribose] synthase 3; pADPRT-3 (PARP3 ADPRT3 ADPRTL3) poly [ADP-ribose] polymerase 4; PARP-4; 193 kD vault protein; PARP-related/IalphaI-related H5/proline-rich; PH5P; vault poly(ADP-ribose) polymerase; VPARP (PARP4, ADPRTL1, KIAA0177, PARPL) poly [ADP-ribose] polymerase 6; PARP-6; ADP-ribosyltransferase diphtheria toxin-like 17; ARTD17 (PARP6) poly [ADP-ribose] polymerase 7; ADP-ribosyltransferase diphtheria toxin-like 14; ARTD14; TCDD-inducible poly [ADP-ribose] polymerase; PARP-7 (TIPARP PARP7) poly [ADP-ribose] polymerase 8; PARP-8; ADP-ribosyltransferase diphtheria toxin-like 16; ARTD16 (PARP8) poly [ADP-ribose] polymerase 9; PARP-9; B aggressive lymphoma protein (PARP9, BAL)

General

ADP-ribosyltransferase

Figures/Diagrams

Mechanism of base excision repair (v.2)

Properties

SIZE: MW = 113 kD entity length = 1013 aa MOTIF: DNA-binding motif SITE: 1-371 MOTIF: nuclear translocation signal {206-208} <1/2SITE> nuclear translocation signal {220-225} <1/2SITE> BRCA1 C-terminal (BRCT) motif SITE: 384-460 automodification {372-523} MOTIF: binding site (15) SITE: 406-519 FOR-BINDING-OF: ADP ribose cofactor-binding site [524-1013] FOR-BINDING-OF: NAD active site SITE: 892

References

  1. UniProt :accession P09874
  2. Lindahl T et al Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. TIBS 20:405 1995 PMID: 853315